Cephalon Inc. | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2020 | private lawsuit-federal | $48,000,000 |
Watson Laboratories | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2016 | private lawsuit-state | $50,000,000 |
Teva Pharmaceuticals Inc. | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2019 | private lawsuit-federal | $54,000,000 |
Andrx Corporation | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2003 | private lawsuit-federal | $55,000,000 |
Teva Pharmaceutical Industries Ltd. | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2019 | CA-AG | $69,000,000 |
Watson Pharmaceuticals | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2011 | MULTI-AG | $70,000,000 |
Teva | Teva Pharmaceutical Industries | pharmaceuticals | off-label or unapproved promotion of medical products | 2024 | MD-AG | $70,281,867 |
Actavis Inc. | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2018 | private lawsuit-federal | $71,000,000 |
Teva Pharmaceuticals, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | off-label or unapproved promotion of medical products | 2023 | KY-AG | $71,477,474 |
Teva Pharmaceuticals USA Inc. | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2017 | private lawsuit-federal | $73,000,000 |
Watson Pharmaceuticals, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2012 | private lawsuit-federal | $79,000,000 |
Teva Pharmaceutical Industries | Teva Pharmaceutical Industries | pharmaceuticals | off-label or unapproved promotion of medical products | 2022 | WV-AG | $83,000,000 |
Teva Pharmaceuticals | Teva Pharmaceutical Industries | pharmaceuticals | Controlled Substances Act violation | 2019 | OK-AG | $85,000,000 |
Cephalon Inc. | Teva Pharmaceutical Industries | pharmaceuticals | off-label or unapproved promotion of medical products | 2008 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $116,000,000 |
Actavis Mid-Atlantic LLC | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $118,614,000 |
Cephalon | Teva Pharmaceutical Industries | pharmaceuticals | consumer protection violation | 2016 | MULTI-AG | $125,000,000 |
Bank Leumi | Bank Leumi | financial services | tax violations | 2014 | NY-DFS | $130,000,000 |
Teva Pharmaceuticals Inc. | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2010 | MULTI-AG | $169,000,000 |
Bank Hapoalim B.M. | Bank Hapoalim | financial services | tax violations | 2020 | NY-DFS | $220,000,000 |
Teva Pharmaceutical Industries Ltd. | Teva Pharmaceutical Industries | pharmaceuticals | off-label or unapproved promotion of medical products | 2022 | TX-AG | $225,000,000 |
Barr Laboratories Inc. | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2017 | private lawsuit-state | $225,000,000 |
Teva Pharmaceutical Industries Limited | Teva Pharmaceutical Industries | pharmaceuticals | Foreign Corrupt Practices Act | 2016 | SEC | $236,000,000 |
Bank Leumi Group | Bank Leumi | financial services | tax violations | 2014 | DOJ_TAX | $270,000,000 |
Teva Pharmaceuticals Industries Ltd. | Teva Pharmaceutical Industries | pharmaceuticals | product safety violation | 2012 | private lawsuit-federal | $270,000,000 |
Teva Pharmaceuticals USA, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2023 | DOJ_ANTITRUST | $275,000,000 |
Teva Pharmaceutical Industries | Teva Pharmaceutical Industries | pharmaceuticals | off-label or unapproved promotion of medical products | 2022 | FL-AG | $278,826,499 |
Teva Pharmaceutical Industries Ltd | Teva Pharmaceutical Industries | pharmaceuticals | Foreign Corrupt Practices Act | 2016 | DOJ_CRIMINAL | $283,177,348 |
Teva Pharmaceuticals, Ltd. | Teva Pharmaceutical Industries | pharmaceuticals | off-label or unapproved promotion of medical products | 2022 | NY-AG | $313,343,793 |
Cephalon Inc | Teva Pharmaceutical Industries | pharmaceuticals | off-label or unapproved promotion of medical products | 2008 | FDA | $425,000,000 |
Teva Pharmaceuticals USA Inc. | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2015 | private lawsuit-federal | $512,000,000 |
Bank Hapoalim B.M. and Bank Hapoalim (Switzerland) Ltd. | Bank Hapoalim | financial services | tax violations | 2020 | DOJ_TAX | $616,910,000 |
Cephalon, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2015 | FTC | $1,200,000,000 |
Teva Pharmaceuticals | Teva Pharmaceutical Industries | pharmaceuticals | off-label or unapproved promotion of medical products | 2022 | MULTI-AG | $4,250,000,000 |